Celestial Therapeutics
celestialtherapeutics.com
Actively hiring
Infectious Disease Therapeutics
Rare Disease Therapeutics
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$3M
5 rounds on record
Latest round
$850k
Venture round · Sep 2024 · 2 yr ago
Team
51-200
employees, estimated range
Grants
$1.3M
2 grants · CORDIS
Backers
1
StartX
The money's age
Long since its last round
25 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 1, 2025
Won a grant $1M · CORDIS
Sep 3, 2024
Raised a round Venture round $850k · SEC Form D
Sep 3, 2024
Raised a round Venture round $850k · SEC Form D
Apr 11, 2023
Won a grant $290k · CORDIS
Jun 15, 2020
New executive John Fortkort, Executive Officer · SEC Form D
Mar 31, 2020
Raised a round Venture round $1.3M · SEC Form D
2019
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Aug 2025 | $1M | — | CORDIS |
| Venture round | Sep 2024 | $850k | — | SEC Form D |
| Venture round | Sep 2024 | $850k | — | SEC Form D |
| Grant | Apr 2023 | $290k | — | CORDIS |
| Venture round | Mar 2020 | $1.3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | CELESTIAL THERAPEUTICS INC. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Ajay GuptaExecutive Officer, DirectorSEC Form D
Leontis TeryazosExecutive Officer, DirectorSEC Form D
John FortkortExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences' Dual Signal Modulator for the Treatment of…
T cell Based Immunotherapies for Cancer and Chronic Infectious Diseases.
Pulmocide is a biotechnology company developing novel inhaled medicines for pulmonary aspergillosis and other hard-to-treat respiratory…
Mendra is a venture-backed rare-disease biopharma accelerating the development and commercialization of de-risked breakthrough therapies.
Paratek Pharmaceuticals is committed to developing and delivering innovative treatments for serious infectious diseases. Learn about our…
Sidewinder Therapeutics is pioneering the next generation of large molecule precision therapeutics. We aim to deliver new life-saving…
People
Ajay Gupta
Executive Officer, Director
Leontis Teryazos
Executive Officer, Director
John Fortkort
Executive Officer
George Siber
Director
Annelise Barron
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Irvine
United States
HQ
San Diego
United States
Regional office
Celestial Therapeutics, Inc.
3210 Merryfield Row San Diego, CA 92121